US Patent Issued to Societe des Produits Nestle on Oct. 7 for "Compositions and methods for treatment of exocrine pancreatic insufficiency (EPI)" (American, Swiss Inventors)

ALEXANDRIA, Va., Oct. 8 -- United States Patent no. 12,433,316, issued on Oct. 7, was assigned to Societe des Produits Nestle S.A. (Vevey, Switzerland).

"Compositions and methods for treatment of exocrine pancreatic insufficiency (EPI)" was invented by Rinat Ran-Ressler (Bridgewater, N.J.), David Stephane Philippe (Auboranges, Switzerland) and Jissy Jacob (Whitehouse Station, N.J.).

According to the abstract* released by the U.S. Patent & Trademark Office: "A method of treating exocrine pancreatic insufficiency includes administering to an individual in need thereof (e.g., an individual with cystic fibrosis) an effective amount of an enteral composition having a total protein consisting essentially of hydrolyzed protein and a total fat co...